Delivery Order SPE2DB20D2001-SPE2DB25FPNLN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,178.96 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 150 mg, with an ultimate completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,184.59 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xcopri 200 mg tablets (30-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $3,927.06 delivery order to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside contract is structured as a firm fixed price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Xcopri is a prescription anticonvulsant medication used in epilepsy treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $6,848.28. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $1,800.99. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by September 8, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count units) on May 20, 2025, with an ultimate completion date of May 21, 2025. This firm fixed-price delivery order, valued at $1,768.44, represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract is issued as a child order under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xcopri 150 mg tablets (30-count units) under a firm fixed price contract valued at $1,393.98. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item procurement of this neurological...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,357.92. This firm fixed-price delivery order, which has an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 200 mg tablets (30-count units) on November 5, 2025, with a ceiling value of $1,206.27. This firm fixed-price delivery order, which is not set-aside, is to be completed by November 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNLNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,503.97 to AmerisourceBergen Drug Corp for Xcopri 150 mg tablets (30-count units) on August 14, 2025, with completion targeted for August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime contractor supporting military and veteran healthcare systems through comprehensive pharmaceutical supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. Xcopri, an anticonvulsant medication, supports the Defense Health Agency and other government healthcare systems' medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/14/25 |